We focus on FDA-approved GLP-1 care pathways.
Can Mounjaro be covered for weight loss?
This sits between medication selection and the insurance-coverage check in the care pathway.
Mounjaro and Zepbound contain the same active ingredient, tirzepatide, but they have different FDA-approved indications. FDA lists Mounjaro as approved to improve blood sugar control in adults with type 2 diabetes, while Zepbound is approved for chronic weight management in certain adults with obesity or overweight. (fda.gov)
Insurance plans may evaluate coverage based on the specific product, the diagnosis or indication submitted, formulary rules, and utilization-management requirements. Coverage is not determined solely by the fact that the medicines share an active ingredient.
Review your plan’s drug list or contact the insurer before filling a prescription. Ask whether Mounjaro or Zepbound is covered for the intended indication and whether prior authorization, step therapy, or other requirements apply.
If the plan does not cover the requested product or indication, ask the insurer to explain the decision and the available review or appeal process. Coverage rules can differ between employer plans, individual plans, Medicare, and Medicaid.